<DOC>
	<DOCNO>NCT00208260</DOCNO>
	<brief_summary>Randomized , open label , multicentre phase II trial follow phase III compare overall survival select best experimental arm .</brief_summary>
	<brief_title>Intensified Chemotherapy CRC After Resection Liver Metastases</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>Histologically proven adenocarcinoma colon rectum without previous resection , clinically asymptomatic ( without stent ) Hepatic unresectable metastasis R0 : due close vascular contact , due liver remain mass le 25 30 % functional liver . Not optimally resectable metastasis Extrahepatic disease accept case : asymptomatic primary tumour tumor require urgent surgery ( le 3 month ) ; three less three lung metastasis ( thoracic scan diameter le 2 cm ) potentially respectable . Synchronous metachronous hepatic metastasis WHO performance status 01 Adjuvant chemotherapy allow , except oxaliplatin irinotecan base combination . No prior treatment liver metastasis , whatever . Life expectancy equal 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>